by Amy Berger | Feb 12, 2025 | Blog, News
Per New Guidance – COVID-19 Research Now Under BSL-2, Offering Cost-Effective Solutions at IITRI We are pleased to announce that recent updates from the CDC and NIH now permit handling SARS-CoV-2 under Biosafety Level 2 (BSL-2) conditions for specific...
by Amy Berger | Feb 4, 2025 | Blog
The Importance of CRO Experience and Capabilities in Cancer Research On this World Cancer Day, we celebrate the remarkable progress made in the fight against cancer and the crucial role that contract research organizations (CROs) like IITRI play in this global effort....
Recent Comments